0001382963-19-000119.txt : 20191107
0001382963-19-000119.hdr.sgml : 20191107
20191107204413
ACCESSION NUMBER: 0001382963-19-000119
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20191107
FILED AS OF DATE: 20191107
DATE AS OF CHANGE: 20191107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Georgiadis Anna
CENTRAL INDEX KEY: 0001789559
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38238
FILM NUMBER: 191201873
MAIL ADDRESS:
STREET 1: 235 YORKLAND BLVD.
STREET 2: SUITE 900
CITY: TORONTO
STATE: A6
ZIP: M2J 4Y8
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Venus Concept Inc.
CENTRAL INDEX KEY: 0001409269
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 061681204
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 235 YORKLAND BLVD.
STREET 2: SUITE 900
CITY: TORONTO
STATE: A6
ZIP: M2J 4Y8
BUSINESS PHONE: 877-848-8430 X117
MAIL ADDRESS:
STREET 1: 235 YORKLAND BLVD.
STREET 2: SUITE 900
CITY: TORONTO
STATE: A6
ZIP: M2J 4Y8
FORMER COMPANY:
FORMER CONFORMED NAME: Restoration Robotics, Inc.
DATE OF NAME CHANGE: 20171121
FORMER COMPANY:
FORMER CONFORMED NAME: Restoration Robotics Inc
DATE OF NAME CHANGE: 20070808
4
1
edgar.xml
PRIMARY DOCUMENT
X0306
4
2019-11-07
0001409269
Venus Concept Inc.
VERO
0001789559
Georgiadis Anna
C/O VENUS CONCEPT INC.
235 YORKLAND BLVD., SUITE 900
TORONTO
A6
M2J 4Y8
ONTARIO, CANADA
0
1
0
0
VP, Global Human Resources
Employee Stock Options (right to buy)
7.95
2019-11-07
4
A
0
28835
A
2028-09-28
Common Stock
28835
28835
D
As of the Transaction Date, 7,808 of these options to acquire Common Stock of the Issuer are fully vested and exercisable. The remaining balance of 21,027 options vest ratably and become exercisable each month from November 28, 2019 to September 28, 2022.
Received, in connection with the merger of a wholly-owned subsidiary of Restoration Robotics, Inc. with and into Venus Concept Ltd. in exchange for an employee stock option to acquire 50,000 Venus Concept Ltd. ordinary shares with an original exercise price of $4.57 per share.
/s/ Domenic Di Sisto, attorney-in-fact
2019-11-07